Invesco Ltd. Xenon Pharmaceuticals Inc. Transaction History

Invesco Ltd.

$503 Billion
Q1 2025

A detailed history of Invesco Ltd. transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Invesco Ltd. holds 205,763 shares of XENE stock, worth $6.67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

205,763

Previous 209,554 1.81%

Holding current value

$6.67 Million

Previous $8.21 Million 15.96%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$33.55 - $40.74 $127,188 - $154,445	-3,791 Reduced 1.81%	205,763 $6.9 Million
Q4 2024 Feb 13, 2025	SELL	$38.14 - $45.74 $239,061 - $286,698	-6,268 Reduced 2.9%	209,554 $8.21 Million
Q3 2024 Nov 12, 2024	SELL	$36.12 - $43.96 $23.5 Million - $28.6 Million	-650,963 Reduced 75.1%	215,822 $8.49 Million
Q2 2024 Aug 13, 2024	SELL	$36.25 - $43.75 $6.62 Million - $7.99 Million	-182,741 Reduced 17.41%	866,785 $33.8 Million
Q1 2024 May 14, 2024	BUY	$42.66 - $50.04 $14.1 Million - $16.5 Million	329,808 Added 45.82%	1,049,526 $45.2 Million
Q4 2023 Feb 12, 2024	BUY	$28.7 - $46.46 $98,010 - $158,660	3,415 Added 0.48%	719,718 $33.2 Million
Q3 2023 Nov 13, 2023	BUY	$34.16 - $39.73 $557,422 - $648,314	16,318 Added 2.33%	716,303 $24.5 Million
Q2 2023 Aug 11, 2023	BUY	$34.84 - $43.54 $23.8 Million - $29.8 Million	683,514 Added 4149.8%	699,985 $26.9 Million
Q1 2023 May 12, 2023	BUY	$33.46 - $40.35 $551,119 - $664,604	16,471 New	16,471 $589,000
Q2 2022 Aug 15, 2022	SELL	$25.44 - $35.16 $5.05 Million - $6.99 Million	-198,701 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$25.09 - $33.13 $2.39 Million - $3.16 Million	-95,399 Reduced 32.44%	198,701 $6.07 Million
Q4 2021 Feb 14, 2022	BUY	$15.6 - $35.4 $4.59 Million - $10.4 Million	294,100 New	294,100 $9.19 Million
Q1 2020 May 15, 2020	SELL	$8.08 - $17.57 $100,272 - $218,043	-12,410 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$8.11 - $14.65 $15,125 - $27,322	1,865 Added 17.69%	12,410 $163,000
Q3 2019 Nov 14, 2019	SELL	$8.74 - $10.51 $28,955 - $34,819	-3,313 Reduced 23.91%	10,545 $95,000
Q2 2019 Aug 14, 2019	BUY	$8.51 - $10.75 $117,931 - $148,973	13,858 New	13,858 $137,000

Others Institutions Holding XENE

# of Institutions

219

Shares Held

69.9M

Call Options Held

444K

Put Options Held

207K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.02B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account